Skip to main content
Open this photo in gallery:

Chief Public Health Officer Theresa Tam responds to a question during a news conference, Dec. 1, 2020 in Ottawa.Adrian Wyld/The Canadian Press

Canada’s chief public health officer says the first doses of Pfizer’s COVID-19 vaccine are likely to be given only to people who can physically be at one of the 14 delivery sites identified by provincial governments for the first arrivals of the vaccine.

Dr. Theresa Tam said at a briefing Tuesday that it is a “rapidly evolving situation” but acknowledged this will make it difficult to get long-term care residents vaccinated first.

“It’s true you cannot move residents very easily from a long-term care centre to a vaccine site,” she said. “That’s just the reality.”

It is not clear how this jibes with some provincial plans, including in Quebec, where the health minister said Monday the government intends to ship its first vaccine doses to two long-term care homes.

The Pfizer vaccine, being produced in partnership with Germany’s BioNTech, is in the final stages of review by Health Canada, which is expected to issue a decision this week. Prime Minister Justin Trudeau said Monday if the approval comes as expected, Canada will receive the first doses next week, and up to 249,000 doses by the end of the month.

Pfizer Canada spokeswoman Christina Antoniou told The Canadian Press that the company is asking for those doses at first to be given only at the first 14 delivery sites.

She said where the vaccine can be injected is “part of ongoing discussions” with provincial governments, who are in charge of getting the vaccine into patients. But she noted Pfizer’s actual contract for the COVID-19 vaccine is with the federal government.

“Pfizer, the Public Health Agency of Canada and the provinces are working together to finalize preparations at the first point of use sites this week, including training on how to handle the product,” she said.

The Pfizer vaccine has very strict requirements, including that it be kept at temperatures below -70 C, which has made shipping it more difficult logistically.

Maj.-Gen. Dany Fortin, named vice-president for logistics at the Public Health Agency of Canada to oversee the vaccine rollout, said a trial run of deliveries began Monday and is still under way.

Boxes were sent from the manufacturing site in Belgium, filled with dry ice but no vaccines, to all 14 sites identified by provincial governments as capable of maintaining the temperature.

Eventually, Fortin said, there will be more than 200 sites, and they will be added as more doses become available and more people can be trained to properly handle the deliveries.

Initially, there are two sites each in Ontario, Quebec, British Columbia and Alberta, and one in each of the other six provinces. Most of them are at hospitals. Ontario Health Minister Christine Elliott said there are 21 hospitals in her province with the freezer requirements.

It is also too difficult to ship the Pfizer vaccine north to remote Indigenous communities. That means two of the four priority groups identified for initial vaccines aren’t likely to get access to the first rounds of vaccinations.

The National Advisory Committee on Immunization recommended last week the first doses go to residents of long-term care and their caregivers, front-line health workers, people over the age of 80 and adults in Indigenous communities where an outbreak would be harder to manage.

Most provinces are following those recommendations almost exactly.

The United Kingdom began vaccinating people with the Pfizer shots Tuesday, after last week being the first country to approve the vaccine.

Intergovernmental Affairs Minister Dominic LeBlanc said an expected executive order from U.S. President Donald Trump to prioritize Pfizer doses for Americans should not affect Canada’s expected deliveries.

LeBlanc says concerns about dose supplies were contemplated when the contracts were signed to ensure supplies could come from more than one location.

Canada’s first doses of Pfizer’s vaccine are to come from lots produced at the company’s plant in Belgium.

Tam says the exciting news about the vaccine is welcome but warns it will be some time before enough doses are injected to control the COVID-19 pandemic.

She said there are now more than 71,000 active cases of COVID-19 nationally, according to figures from Monday, and an average of 92 people are dying of the illness every day. Hospitals in many provinces are feeling the pandemic’s pressure, with more than 2,680 people being treated for COVID-19 in hospitals, almost one-fifth of those in critical care.

Quebec Premier Francois Legault warned there may be more lockdown measures coming in that province as hospitalizations continued to rise, hitting 835 Tuesday. That is up by nearly 100 patients compared to a week ago.

Saskatchewan logged its deadliest day from the virus thus far, with six deaths, including one person in their 30s.

Nunavut provided a bright spot of news in the pandemic fight Tuesday, with chief public health officer Dr. Michael Patterson noting a milestone had occurred in the territory’s recovery from its first outbreak.

Last month Patterson warned the limited health capacity in Nunavut couldn’t handle much more as four communities struggled with cases. On Tuesday he said three of those four were back to zero cases. There was one new case in Arviat.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe